Home > Financial Ratios > BIOCON

BIOCON
Working Capital/Sales

    Back to All Ratios
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 7.86-83.122.951.802.11

What is the latest Working Capital/Sales ratio of BIOCON ?

The latest Working Capital/Sales ratio of BIOCON is 7.86 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20257.86
Mar2024-83.12
Mar20232.95
Mar20221.80
Mar20212.11

How is Working Capital/Sales of BIOCON Trending?

Years Working Capital/Sales % Change
Mar2025 7.86
Positive
Mar2024 -83.12
Negative
Mar2023 2.95
63.89
Mar2022 1.8
-14.69
Mar2021 2.11 -

Other Financial Ratios of BIOCON


Compare Working Capital/Sales ratio of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹58,279.5 Cr 2.8% -2.9% 16.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,848.0 Cr 11.6% 0.7% -0.4% Stock Analytics
DIVIS LABORATORIES ₹172,697.0 Cr 2.3% 8.5% 8.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,859.0 Cr 1.8% -1.8% 30.7% Stock Analytics
DR REDDYS LABORATORIES ₹110,421.0 Cr 0.5% 3.2% 13.3% Stock Analytics
CIPLA ₹105,811.0 Cr 1.2% 5.4% -13.7% Stock Analytics


BIOCON Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

2.8%

-2.9%

16.1%

SENSEX

-1%

2.2%

-3.6%


You may also like the below Video Courses